Elizabeth Miles

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Christopher M. Nutting, James P. Morden, Kevin J. Harrington et al. · The Lancet Oncology · 2011 · 1.7K citations · Full text

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 988 citations · Full text

The impact of introducing intensity modulated radiotherapy into routine clinical practice

Elizabeth Miles, Catharine H. Clark, Teresa Guerrero Urbano et al. · Radiotherapy and Oncology · 2005 · 115 citations

Adaptive Radiotherapy, Radiation Medicine, Radiation Therapy +8

Variability of bladder filling in patients receiving radical radiotherapy to the prostate

Úna M. O'Doherty, H. McNair, A. Norman et al. · Radiotherapy and Oncology · 2006 · 114 citations

Urogenital Radiology, Radiation Medicine, Urology +8

DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

Imran Petkar, Keith Rooney, Justin Roe et al. · BMC Cancer · 2016 · 109 citations · Full text